March 31 (Reuters) - Selvita SA SLV1.WA :
* ADOPTS GROUP STRATEGY FOR 2022-2025
* UNDER STRATEGY PLANS TO TRIPLE SALES REVENUE TO ABOUT 900
MILLION ZLOTYS MAINTAINING HIGH PROFITABILITY
* UNDER STRATEGY PLANS TO IMPLEMENT STRATEGY VIA ORGANIC
GROWTH
AND ACQUISITIONS
* UNDER STRATEGY PLANS TO EXPAND DRUG DISCOVERY OFFER AND
BUILD
DRUG DEVELOPMENT SEGMENT
* UNDER STRATEGY PLANS TO SPECIALISE IN SELECTED
THERAPEUTIC
AREAS
* FOR IMPLEMENTATION OF STRATEGY COMPANY PLANS TO CONTRIBUTE
TOTAL
OF ABOUT 950 MILLION ZLOTYS
* OUT OF THIS AMOUNT ABOUT 180 MILLION ZLOTYS WILL GO TO
FINANCE
ORGANIC GROWTH, WHEREAS ABOUT 270 MILLION ZLOTYS WILL GO TO
EXPANSION OF LABORATORY INFRASTRUCTURE
* OUT OF THIS AMOUNT ABOUT 500 MILLION ZLOTYS WILL BE
ALLOCATED
FOR ACQUISITIONS
Source text for Eikon: ID:nEMcbrDtwa
Further company coverage: SLV1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))